This week’s Research Roundup highlights the best tumor size cut-points for renal cell carcinoma staging.
This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.